Newsroom
September 15, 2020
Tuesday, 15th September, 2020: Excelra, a global data science and data analytics company, today announced its collaboration with Standigm Inc., a company using artificial intelligence (AI) technology for drug discovery and development. September 15, 2020. Read More
July 23, 2020
Thursday, 23rd July, 2020: Excelra announced today the appointment of Haranath Gnana as Chief Solutions Officer effective July 22, 2020. Read More
June 10, 2020
Wednesday, 10th June, 2020:Excelra announced the release of the COVID-19 Biomarker Database in support of the ongoing global scientific efforts, aimed at developing safe and effective therapeutic options to treat the novel coronavirus disease. Read More
May 19, 2020
Tuesday, 19th May, 2020: Under a three-year agreement, Excelra will provide Lawrence Livermore National Laboratory (LLNL) with GOSTAR, a small molecule medical chemistry intelligence database to aid drug design projects. Read More
April 8, 2020
Wednesday, 8th April, 2020: The ‘open-access’ database presents a landscape of ‘Approved’ small molecules and biologics with known preclinical, pharmacokinetic, pharmacodynamic, and toxicity profiles; which can rapidly enter either Phase 2 or 3 or may even be used directly in clinical settings against COVID-19. Read More
March 16, 2020
Monday, 16th March, 2020: Excelra has activated its business contingency plan to avoid or minimize business disruptions and ensure seamless delivery. Read More
February 6, 2020
Thursday, 6th February, 2020: Excelra’s Dr. Nandu Gattu, (Senior Vice President – Pharma Analytics) interviewed for ‘PharmaVoice’ on the topic “New Pipeline Pathways”. Dr. Gattu elucidated on data-driven and strategic approaches to ‘Drug Repurposing’. Read More
December 18, 2019
HYDERABAD India, December 18th Wednesday, 2019: Excelra (www.excelra.com), a leading global Data and Analytics company, today announced a Drug Repurposing partnership with Keio University School of Medicine – a top research university in Japan to explore new therapeutics for a rare indication. . Read More
November 20, 2019
HYDERABAD India, November 20th Wednesday, 2019: Excelra (www.excelra.com), a leading global Data and Analytics Company today announced a Drug Repurposing collaboration with Osaka-based Maruho – a pharmaceutical company specialising in Dermatology. Read More
April 8, 2019
HYDERABAD, India – 8th April, 2019 — Excelra (www.excelra.com), a leading data and analytics company, announced the successful release of GOBIOM+ (Global Online Biomarker Database), the most comprehensive and high-quality biomarker intelligence platform. GOBIOM+ is geared to support quick, reliable and data-driven decision making in translational drug development. Read More…
Aug 27, 2018
Dr. Nandu Gattu, senior vice-president pharma analytics at Excelra, a biopharma data and analytics company, noted that osimertinib is significantly more expensive (estimated at three-10 times) than the first- and second-generation EGFR inhibitors and this may play as a key factor in clinical use. Read More…
May 16, 2018
Excelra and IIT-Kharagpur announce a multi-year collaboration aimed at accelerating research in Drug Repurposing. The alliance will leverage diverse skill-sets and domain expertise of the two partners and integrate Natural Language Processing (NLP) and Machine Learning (ML) technology in Excelra’s Drug Repurposing engine. Read More…
November 13, 2017
Anandbir Singh Brar, CEO at EXCELRA was elated to talk on the development and noted, “Our collaboration has started gaining the momentum required to deliver unprecedented results. This is just the beginning. Read More…
November 21, 2016
Based on its recent analysis of the biomarker research market, Frost & Sullivan recognizes Excelra Knowledge Solutions Pvt. Ltd. with the 2016 North American Frost & Sullivan Award for Enabling Technology Leadership. Excelra’s comprehensive, content-rich biomarker database. Read More…
July 19, 2016
Dr. Nandu Gattu heads the Pharma Analytics Group at Excelra. He has more than 25 years of experience in Computational Biology, Pharmacology and Drug Discovery & Development. Prior to joining Excelra, Dr. Gattu was associated with Schering Plough Pharmaceuticals, SmithKline Beecham, GlaxoSmithKline and Vimta Labs. Read More…
June 07, 2016
Excelra, Asia’s leading Knowledge Solutions Company today announced that it has entered into a strategic Drug Repurposing collaboration with Tokyo-based pharmaceutical company, Astellas Pharma Inc. The collaboration is focused on identifying novel therapeutic indications. Read More…
May 13, 2016
Excelra, Asia’s leading knowledge solutions company today announced its collaboration with H.M. Pharma Consultancy (HMPC), a life science consulting enterprise based in Austria, to jointly provide Drug repurposing services to Pharma and Biotech companies across Europe. Read More…
April 26, 2016
Excelra Knowledge Solutions today announced that it has extended its GOBIOM (Global Online Biomarker Database) license to the Biomarker Qualification Group of the USFDA. Excelra collaborated with the USFDA in the year 2008 in developing the safety biomarker content in GOBIOM. Read More…